Samara R. Wilson

Samara R. Wilson

Auto-generated profile, based on publicly available information

Samara R. Wilson

School of Psychological Sciences, Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2019 in Addiction
Verified
Journal Article
Open access
PDF file
SWSamara Wilson
Samara Wilson
TPTimea Partos
Timea Partos
AMAnn Mcneill
Ann Mcneill
LBLeonie Brose
Leonie Brose
Background and aims: E‐cigarettes (EC) and nicotine replacement therapy (NRT) are less harmful than smoking, but misperceptions of relative harm are common. Aims were to (1) assess nicotine knowledge and perceptions of: harm of EC and NRT relative to smoking, addictiveness of EC relative to smoking, and change in harm to user if smoking replaced with EC; (2) define associations of these perceptions with respondent characteristics including nicotine knowledge; and (3) explore perceived main harms of EC and whether these differ by vaping status.Design: Analyses were: (1) frequencies; (2) logistic regressions of perceptions of relative harm, addictiveness and change in harm onto demographics, smoking and vaping status and nicotine knowledge (attributing cancer or health risks of smoking to nicotine); and (3) frequencies and χ2 statistics.Setting and participants: Participants were smokers and recent ex‐smokers from one wave (September 2017) of a longitudinal online survey in the United Kingdom (n = 1720).Measurements: Demographics included gender, age, smoking status, vaping status and income. Survey questions collected data on nicotine knowledge and harm perceptions of different products; the relative harm perceptions of NRT, EC and tobacco cigarettes; and perceived main harms of EC.Findings: Relative to smoking, 57.3% perceived EC and 63.4% NRT to be less harmful; 25.4% perceived EC to be less addictive; and 32.2% thought replacing smoking with EC reduced health harms a great deal. Participants were less likely to endorse these beliefs if they had never vaped, and participants who had inaccurate nicotine knowledge were less likely to endorse all these beliefs apart from the addictiveness of EC. The main concerns about EC were a lack of research (48.3%), regulation or quality control (37.8%) and harmfulness of chemicals (41.6%).Conclusions: Large proportions of UK smokers and ex‐smokers overestimate the relative harmfulness of e‐cigarettes and nicotine replacement therapy compared with smoking; misattributing smoking harms to nicotine is associated with increased misperceptions.

7 September 2017 in Addiction Research & Theory
Verified
Journal Article
Closed access
SWSamara R. Wilson
Samara R. Wilson
DLDan I. Lubman
Dan I. Lubman
SRSimone Rodda
Simone Rodda
VMVictoria Manning
Victoria Manning
MYMarie Yap
Marie Yap
Background: Previous studies have identified that problematic alcohol and other drug (AOD) use has major impacts on family members. Work with partners suggests they experience mental health problems, such as depression, anxiety, or stress, which arise from feelings of helplessness, self-blame, uncertainty, worry, conflict and disruption to family life. However, most studies have focussed on interviews with participants purposively recruited from face-to-face settings. Whether these issues are common to a broader range of partners seeking help and advice from online services requires further study. Method: One hundred synchronous online chat counselling transcripts of partners of individuals with problem AOD use were sampled from a 24-hour national online counselling service in Australia. Thematic analysis was used to look at the personal impacts reported by these partners. Results: The personal impacts identified were reflected in partners’ cognitions (depressive cognitions, responsibility beliefs, and thoughts around trust), behaviours (helpful and unhelpful coping) and emotions (anger, sadness, and fear). Conclusions: These findings highlight the substantial burden that problematic AOD use imposes on intimate partners personally, reinforcing the need for services to engage partners as valid help-seekers in their own right.

31 May 2018 in Drugs: Education, Prevention and Policy
Verified
Journal Article
Closed access
SWSamara R. Wilson
Samara R. Wilson
DLDan I. Lubman
Dan I. Lubman
SRSimone Rodda
Simone Rodda
VMVictoria Manning
Victoria Manning
MYMarie Yap
Marie Yap
Background: Problem alcohol or other drug (AOD) use can have severe impacts on partners interpersonally, including both their intimate relationship, as well as their interactions with friends and family. Previous research has predominantly focussed on spouses of problem drinkers, and recruited individuals who have experienced significant harm requiring medical or legal services. This paper sought to explore the breadth of interpersonal impacts on a broader range of partners, to better inform service provision. Method: One hundred synchronous online counselling transcripts of partners (85% female, aged 15 to over 65 years) of individuals with problem AOD use were sampled from a 24-hour national online AOD counselling service. A thematic analysis was conducted, exploring the interpersonal impact on partners. Findings: Interpersonal impacts included intimate relationship issues (discovery leads to communication difficulties; decisions to stay or leave), challenges in parenting (safety and well-being concerns; exposure to problem AOD use impacts; difficulty managing parenting responsibilities; pregnancy-related considerations), and impacts on and from their social network (benefits and challenges in seeking social support; extended family and social group stressors/support). Conclusions: Interpersonal impacts are multi-faceted, and partners should have access to targeted referrals for relationship assistance, peer support (online or face-to-face), domestic violence and welfare services.

1 July 2017 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
SWSamara R. Wilson
Samara R. Wilson
SRSimone Rodda
Simone Rodda
DLDan I. Lubman
Dan I. Lubman
VMVictoria Manning
Victoria Manning
MYMarie Yap
Marie Yap

25 January 2019 in Nicotine & Tobacco Research
Verified
Journal Article
Open access
PDF file
HLHyun S Lee
Hyun S Lee
SWSamara Wilson
Samara Wilson
TPTimea Partos
Timea Partos
AMAnn Mcneill
Ann Mcneill
LBLeonie Brose
Leonie Brose
In line with the European Union’s Tobacco Products Directive (TPD), new regulations for electronic cigarettes implemented in the United Kingdom between May 2016 and May 2017 included limiting refills to 10 mL, tank and cartridge sizes to 2 mL, and nicotine concentrations to 20 mg/mL. To investigate the (1) awareness of new regulations, (2) product use before and after implementation, and (3) association between use of compliant products and subsequent smoking. A UK online longitudinal survey of smokers, ex-smokers, and vapers was conducted between May and June 2016 (wave 4) and September 2017 (wave 5).The following methods were used: (1) to assess awareness of changes, proportions were calculated by smoking and vaping status (n = 1606). (2) Comparison of refill volume, tank and cartridge volumes, nicotine concentration at waves 4 and 5 (n = 199–388) was conducted. (3) Association was studied between number of TPD-compliant products used at wave 4 and smoking at wave 5, adjusted for wave 4 vaping status, age, gender, income, urges to smoke, and device type (n = 480). Awareness of regulations was highest for refill volume (10.1%; 37.4% among exclusive vapers) and nicotine concentration (9.5%; 27.3%). Higher proportions used TPD-compliant refill volumes (60.0%–73.7%, χ2(1) = 10.9, p = .001) and nicotine concentrations (89.2%–93.9%, χ2(1) = 7.41, p = .007) in wave 5 than wave 4, with little change for tank or cartridge volumes (77.1–75.5%, χ2(1) = 0.38, p = .540). The likelihood of smoking was similar for those using no or one TPD-compliant products as it was for those using two (OR = 1.10, 95% CI = 0.47–2.59) or three (OR = 1.56, 95% CI = 0.69–3.55). Several months after full implementation, awareness of new regulations was low and most vapers used TPD-compliant products. Use of compliant products was not associated with subsequent smoking. Using a longitudinal survey at the beginning and a few months after the end of the transition period for implementation of new regulation on electronic cigarettes, this is the first study to assess awareness of regulation and use of compliant products. After full implementation, awareness of changes was low overall (smokers, ex-smokers, and vapers combined) although higher among those who vaped. Nevertheless, most vapers (74%–94%) used products that were compliant with the new regulations and the use of products compliant with incoming regulations did not predict whether they were smoking cigarettes after implementation.